Table:
begin	end	state
1	39	cytoplasmic
40	59	transmembrane
60	70	non-cytoplasmic
71	94	transmembrane
95	105	cytoplasmic
106	127	transmembrane
128	129	non-cytoplasmic
130	155	transmembrane
156	174	cytoplasmic
175	196	transmembrane
197	205	non-cytoplasmic
206	227	transmembrane
228	264	cytoplasmic
265	286	transmembrane
287	300	non-cytoplasmic
301	319	transmembrane
320	330	cytoplasmic
331	350	transmembrane
351	361	non-cytoplasmic
362	383	transmembrane
384	390	cytoplasmic
391	415	transmembrane
416	424	non-cytoplasmic
425	443	transmembrane
444	489	cytoplasmic

Input:
>WP_011880619.1 NCBI__GCF_000016205.1:WP_011880619.1
MSSPHAHSAKTRSSRQALKLDDITIVDRAILKRAVGAMAFGNAMEWFDFGVYSYIAVTLG
KVFFPSSSPSAQLLATFGTFAAAFVVRPLGGMVFGPLGDRIGRQRVLAATMIMMAVGTFA
IGLIPSYASIGIMAPVLLLVARLVQGFSTGGEYGGAATFIAEFSTDKRRGFMGSFLEFGT
LIGYTLGAATVTLLTATLSHDALLSWGWRVPFFIAGPLGLVGLYIRIKLEETPAFKKEAL
AREADERARPKQSFGTLLVEQWRPLLQCVGLVLIFNVTDYMALSYLPNYLSATLHFNETH
GLFMVLIVMLLMMPMTLYAGHLSDRIGRKPVMMFGCVGLLVLSVPALMLIRTGGMLPVFG
GMLIYGTLLSTFTGVMPSALPALFPTRIRYGALAIGFNVSVSLFGGTTPLVTAWLVDRTG
DLMMPAYYLMGASFIGIVSVLALRESARRPLPGSTPCVGSRAEAQELIRRGAGEVRGRER
KLTPIGERA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server